• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Interventional Phase IIIb/ Phase IV Clinical Trials

  • clinical-trials-header
  • Quintiles Clinical Trial

    In the last three years, we’ve conducted more than 225 Phase IIIb and Phase IV trials

    You spend millions of dollars and years developing your product to gain market approval. The demand for post-marketing evidence in larger populations may lead to additional interventional clinical trials. But your budget and timeline aren’t endless.

    Post-marketing trials require agility and efficiency:

    • Global infrastructure and site relationships to scale up to deliver large trials quickly and efficiently
    • Integrated expertise in health outcomes, biostatistics, epidemiology and post-marketing regulations 
    • Streamlined operations that reduce time and cost 

    In the last three years, we’ve conducted more than 225 Phase IIIb and Phase IV trials to:

    • Support new indications or label extensions 
    • Obtain or expand market access 
    • Support product differentiation and positioning 
    • Demonstrate efficacy and comparative effectiveness 
    • Meet post-marketing commitments 
    • Evaluate and monitor safety 

  • Industry-leading expertise in Phase IIIB and Phase IV trials

  • Quintiles Clinical Trails

    Louise Parmenter, Ph.D., discusses the increasing demands on companies to deliver strong, holistic evidence to support healthcare decision making. Read white paper

  • Quintiles Clinical Trails

    Different stakeholders demand different types and rigors of evidence—no matter the approach or research question, we have you covered. Learn how Quintiles helps meet any research objective. Read brochure